Federal grants to Accelevir Diagnostics LLC
Accelevir Diagnostics LLC in Baltimore, Maryland received $5.8 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Allergy and Infectious Diseases Research, with $5.8 million. In fiscal 2025 it was awarded $755,300.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$5.8 million
- Awards5
- Awarded in FY 2025$755,300
- Largest award$4.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $1.3 million |
| FY 2022 | 3 | $1.5 million |
| FY 2023 | 1 | $1.5 million |
| FY 2024 | 1 | $749,588 |
| FY 2025 | 1 | $755,300 |
Programs that fund Accelevir Diagnostics LLC
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 5 | $5.8 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $5.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Centralized resource to accurately quantify latent and expressed HIV reservoirs | Allergy and Infectious Diseases Research | March 26, 2021 | $4.1 million |
| Centralized resource to accurately quantify latent and expressed hivreservoirs - project summary/abstract human immunodeficiency virus TYPE-1 (HIV-1) is a retrovirus that infects CD4+ t cells of the immune system. If left untreated, HIV-1 infected individuals will progress to AIDS and may ultimately | Allergy and Infectious Diseases Research | April 9, 2025 | $755,300 |
| Ipda for high-priority HIV-1 subtype c to enable global eradication trials - project summary/abstract human immunodeficiency virus TYPE-1 (HIV-1) is a retrovirus that infects CD4+ t cells of the immune system. If left untreated, HIV-1 infected individuals will progress to AIDS and may ultimately die | Allergy and Infectious Diseases Research | July 6, 2021 | $600,000 |
| HIV-1 envlrs: a scalable, sequence-based assay for in-depth assessment of HIV-1 bnab resistance - project summary/abstract human immunodeficiency virus TYPE-1 (HIV-1) is a retrovirus that infects CD4+ t cells of the immune system. If left untreated, people living with HIV-1 (PLWH) will progress to a | Allergy and Infectious Diseases Research | July 23, 2021 | $300,000 |
| Development of a next-generation quantitative viral outgrowth assay (QVOA) for the standardized measurement of the HIV-1 latent reservoir | Allergy and Infectious Diseases Research | September 26, 2022 | $640 |
Questions people ask
How much federal grant money does Accelevir Diagnostics LLC get?
$5.8 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Accelevir Diagnostics LLC the most?
The Department of Health and Human Services, with $5.8 million in 5 awards.
What is Accelevir Diagnostics LLC's largest federal grant?
$4.1 million under Allergy and Infectious Diseases Research, with its first action in the period on March 26, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Baltimore
- Maryland Department of Health
- Maryland State Department of Education
- The Johns Hopkins University
- Maryland Department of Human Services
- Maryland Department of Transportation
- Maryland Transit Administration
- Catholic Relief Services - United States Conference of Catholic Bishops
- Maryland Health Benefit Exchange
Largest federal grant recipients in Maryland · Federal grants in Maryland